Journal article · 2023

Safety of the JAK and TNF inhibitors in rheumatoid arthritis: real world data from the Hong Kong Biologics Registry

Chi Chiu Mok, Ho So, Cheuk Wan Yim, Chi Hung To, Weng Nga Lao, Stella Pui Yan Wong, Hoi Yan Ng, Jolly Man Yee Lee, Patrick Man Leung Lee, Shirley King Yee Ying, Moon Ho Leung, Carmen Tze Kwan Ho

Rheumatology, 63(2), 358–365 · Published 2 May 2023 · DOI 10.1093/rheumatology/kead198

View at the publisherCite this paper

In brief

“Safety of the JAK and TNF inhibitors in rheumatoid arthritis: real world data from the Hong Kong Biologics Registry” is a 2023 journal article by Chi Chiu Mok and 11 co-authors, published in Rheumatology. OpenAlex counts 36 citations as of 19 November 2026, which puts it in the top 7% of works published in 2023 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
36
Most cited in
2025 (14)
Field-weighted impact
5.99
References
36
Authors
12

Abstract

OBJECTIVES: To compare the incidence of major adverse cardiovascular events (MACEs), cancer and infective complications in RA patients using Janus kinase (JAKis) and TNF (TNFis) inhibitors. METHOD: A retrospective analysis of data from the Hong Kong Biologics Registry 2008-2021 was performed. RA patients who had ever used JAKis or TNFis were included. The incidence of… Read the full abstract at the publisher.

Excerpt. This paper is not open access.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Mok, C. C., So, H., Yim, C. W., To, C. H., Lao, W. N., Wong, S. P. Y., Ng, H. Y., Lee, J. M. Y., Lee, P. M. L., Ying, S. K. Y., Leung, M. H., & Ho, C. T. K. (2023). Safety of the JAK and TNF inhibitors in rheumatoid arthritis: real world data from the Hong Kong Biologics Registry. Rheumatology, 63(2), 358–365. https://doi.org/10.1093/rheumatology/kead198

MLA 9

Mok, Chi Chiu, et al. “Safety of the JAK and TNF inhibitors in rheumatoid arthritis: real world data from the Hong Kong Biologics Registry.” Rheumatology, vol. 63, no. 2, 2023, pp. 358–365. https://doi.org/10.1093/rheumatology/kead198.

Chicago

Mok, Chi Chiu, Ho So, Cheuk Wan Yim, Chi Hung To, Weng Nga Lao, Stella Pui Yan Wong, Hoi Yan Ng, et al. 2023. “Safety of the JAK and TNF inhibitors in rheumatoid arthritis: real world data from the Hong Kong Biologics Registry.” Rheumatology 63 (2): 358–365. https://doi.org/10.1093/rheumatology/kead198.

Harvard

Mok, C. C. et al. (2023) ‘Safety of the JAK and TNF inhibitors in rheumatoid arthritis: real world data from the Hong Kong Biologics Registry’, Rheumatology, 63(2), pp. 358–365. doi:10.1093/rheumatology/kead198.

IEEE

C. C. Mok et al., “Safety of the JAK and TNF inhibitors in rheumatoid arthritis: real world data from the Hong Kong Biologics Registry,” Rheumatology, vol. 63, no. 2, pp. 358–365, 2023, doi: 10.1093/rheumatology/kead198.

BibTeX

@article{mok2023safety,
  title     = {{Safety of the JAK and TNF inhibitors in rheumatoid arthritis: real world data from the Hong Kong Biologics Registry}},
  author    = {Mok, Chi Chiu and So, Ho and Yim, Cheuk Wan and To, Chi Hung and Lao, Weng Nga and Wong, Stella Pui Yan and Ng, Hoi Yan and Lee, Jolly Man Yee and Lee, Patrick Man Leung and Ying, Shirley King Yee and Leung, Moon Ho and Ho, Carmen Tze Kwan},
  journal   = {Rheumatology},
  year      = {2023},
  volume    = {63},
  number    = {2},
  pages     = {358--365},
  doi       = {10.1093/rheumatology/kead198},
  url       = {https://doi.org/10.1093/rheumatology/kead198}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202322
20241111
20251414
202699

Its field-weighted citation impact is 5.99: it has been cited 5.99 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies

  • rheumatoid arthritis
  • JAK inhibitors
  • TNF-alpha inhibitors
  • major adverse cardiovascular events
  • cancer incidence
  • infection risk
  • herpes zoster
  • biologic therapy safety

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Mok, C. C., So, H., Yim, C. W., To, C. H., Lao, W. N., Wong, S. P. Y., Ng, H. Y., Lee, J. M. Y., Lee, P. M. L., Ying, S. K. Y., Leung, M. H., & Ho, C. T. K. (2023). Safety of the JAK and TNF inhibitors in rheumatoid arthritis: real world data from the Hong Kong Biologics Registry. Rheumatology, 63(2), 358–365. https://doi.org/10.1093/rheumatology/kead198

How many times has this paper been cited?

36 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Chi Chiu Mok, Ho So, Cheuk Wan Yim, Chi Hung To, Weng Nga Lao, Stella Pui Yan Wong, Hoi Yan Ng, Jolly Man Yee Lee, Patrick Man Leung Lee, Shirley King Yee Ying, Moon Ho Leung, Carmen Tze Kwan Ho.

What is the DOI of this paper?

10.1093/rheumatology/kead198, permanently at https://doi.org/10.1093/rheumatology/kead198. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.